Regenerative Outcomes for Peri-implant Bony Defects Using Amnion-chorion Barrier vs. Collagen Membrane

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLoma Linda University

About this trial

The purpose of this study is to compare the clinical and radiographic outcomes of two different barrier membranes-amnion-chorion membranes (ACM) and conventional collagen membranes-used in guided bone regeneration (GBR) procedures for the treatment of peri-implantitis. Both membranes are commonly used in clinical practice; however, this study aims to determine whether ACM offers greater benefits in terms of peri-implant probing depth reduction, radiographic bone fill, and patient-reported post-operative healing outcomes. The findings may help inform surgical decision-making and support the use of ACM as a more effective regenerative material for managing peri-implant bony defects.

Eligibility criteria

Qualifiers

Systemically healthy adults (≥18 years) with a diagnosed peri-implantitis lesion requiring surgical intervention of any ethnicity

Comprehension of treatment plan and research project.

Presence of a single implant in function for at least one year.

Radiographic evidence of peri-implant bone loss not exceeding one-third of the implant length.

Disqualifiers

Patients who have had a history of periodontitis, diabetes, smoking habit, or have been prescribed medications that may interfere with bone healing and metabolism

Patients with allergies to any treatment devices

Patients who have a lack of keratinized mucosa (<2 mm), or positioning for implants or restorative designs that compromise oral hygiene

Peri-implant bone defects not attributable to peri-implantitis (e.g. surgical iatrogenic, trauma)

Trial design

Treatments tested in this trial

  • BioXclude Amnion Chorion Membrane
  • Collagen Membrane

Treatment groups

56 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators